Your search for "poultry vaccine production" return 86 results.
CEVA EXPANDS ORAL RABIES VACCINE PORTFOLIO WITH THE ACQUISITION OF CANADIAN FIRM ARTEMIS TECHNOLOGIES, INC. >
Libourne, May 16, 2022 – Ceva Santé Animale (Ceva) has acquired the Canadian oral rabies vaccine manufacturer Artemis Technologies, Inc. Artemis, located in Guelph, ON, Canada, produces ONRAB®, a ra...
Ceva’s U.S. C.H.I.C.K Program receives independently audited quality recognition from Bureau Veritas
Consolidated sales of the Ceva Group reached more than €1.2 billion in 2019.
MAWD Pathology increases same-day COVID-19 testing using equipment on loan from Ceva
Ceva launches a “new wave of innovation” to help poultry producers meet the performance challenges driven by the need for “No antibiotics” and more sustainable production
Industry leaders from around the world recently gathered in Nashville for the 2017 Live Production, Welfare and Biosecurity Seminar.
Live monovalent vaccine aids in fight against Georgia strains of IBV.
2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m.
Ceva Animal Health has planned a number of activities for attendees at the International Production and Processing Exposition (IPPE) taking place this week in Atlanta.
Innovative and experienced leader has joined Ceva Animal Health as director, marketing, for poultry and swine.